← Evidence map

ArticleOncoimmunology

Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer.

Shuai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
pooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30221052